Assessment of Clinical Pharmacy Interventions in the Intensive Care Unit
|
|
- Evelyn McKenzie
- 6 years ago
- Views:
Transcription
1 ORIGINAL RESEARCH Assessment of Clinical Pharmacy Interventions in the Intensive Care Unit Claudia K Ho, Vincent H Mabasa, Vivian W Y Leung, Douglas L Malyuk, and Jerrold L Perrott ABSTRACT Background: Clinical pharmacy services have been shown to reduce adverse drug events and health care costs. However, few studies have assessed their effect on patient outcomes in the intensive care unit (ICU). Objective: To describe characteristics of ICU patients with documented pharmacist interventions and to evaluate the relationships between patients complexity level and pharmacists interventions and between pharmacists interventions and mortality rate. Methods: Inpatient records of admissions between January 1, 2004, and March 31, 2007, were analyzed to identify the presence of clinical pharmacy notes (CPNs). The characteristics of patients with and without CPNs were compared using descriptive statistics. For primary analysis of the association between patient complexity level and presence of CPNs, logistic regression modelling was performed to adjust for potential confounding. Logistic regression was also used to explore the possible association between CPNs and mortality. Finally, mortality analysis was carried out for patients with and without CPNs, with matching by complexity level. Results: The main study cohort comprised 1561 patients: 333 (21.3%) with CPNs and 1228 (78.7%) with no CPNs. A greater proportion of those with a CPN had the highest complexity level: 295 (88.6%) of those with CPNs versus 660 (53.7%) of those with no CPNs. After adjustment for age and sex, the odds ratio for having a CPN among patients with complexity level 4 (relative to patients with lower complexity levels) was 8.20 (95% confidence interval ). Mortality rates were not significantly different between the 2 groups: 26.7% (89/333) among patients with CPNs and 27.9% (343/1228) among those without CPNs (p = 0.66). After adjustment for age, sex, complexity level, and length of stay in the ICU, the presence of a CPN was not significantly associated with mortality. Mortality rates in the matched cohort (n = 1078) were also similar between patients with and without CPNs (89/333 [26.7%] and 226/745 [30.3%], respectively; p = 0.23), and the presence of a CPN was not significantly associated with mortality after adjustments for potential confounding factors. Conclusion: Documenting clinical pharmacy activities is essential for assessing pharmacists impact on patient outcomes. These data suggest that ICU pharmacists prioritize clinical activities to care for the sickest patients. Keywords: clinical pharmacy, documentation, patient outcomes, interventions, mortality, length of stay RÉSUMÉ Contexte : Il a été montré que les services de pharmacie clinique réduisaient les événements indésirables liés aux médicaments et les coûts de soins de santé. En revanche, peu d études ont évalué leurs effets sur les résultats thérapeutiques chez les patients des unités de soins intensifs (USI). Objectif : Décrire les caractéristiques des patients des USI pour lesquels les pharmaciens avaient consignés des interventions et évaluer les liens entre le niveau de complexité de l état des patients et les interventions des pharmaciens et entre les interventions des pharmaciens et le taux de mortalité. Méthodes : Les dossiers des patients hospitalisés entre le 1er janvier 2004 et le 31 mars 2007 ont été analysés à la recherche de notes de pharmaciens cliniciens (NPC). Les caractéristiques des patients dont le dossier comportait des NPC et de ceux dont le dossier n en comportait pas ont été comparées au moyen de statistiques descriptives. L analyse primaire de l association entre le niveau de complexité de l état des patients et la présence de NPC a été réalisée au moyen d un modèle de régression logistique pour compenser les facteurs de confusion potentiels. Ce modèle a aussi été utilisé pour évaluer l association possible entre les NPC et la mortalité. En dernier lieu, une analyse de mortalité a comparé les patients dont le dossier comportait des NPC à ceux dont le dossier n en comportait pas, avec un appariement du niveau de complexité. Résultats : La principale cohorte de l étude comptait 1561 patients : 333 (21,3 %) dont le dossier comportait des NPC et 1228 (78,7 %) dont le dossier n en comportait pas. Une plus grande proportion des patients dont le dossier comportait des NPC présentaient le plus haut niveau de complexité : 295 (88,6 %) de ceux avec des NPC contre 660 (53,7 %) de ceux sans NPC. Après ajustement pour l âge et le sexe, le risque relatif approché de NPC chez les patients présentant un niveau de complexité 4 (par rapport aux patients présentant un niveau de complexité moindre) était de 8,20 (intervalle de confiance à 95 % : 5,44 12,38). Les taux de mortalité n étaient pas significativement différents entre les deux groupes : 26,7 % (89/333) chez les patients avec NPC et 27,9 % (343/1228) chez les patients sans NPC (p = 0,66). Après ajustement pour l âge, le sexe, le niveau de complexité et la durée du séjour à l USI, la présence d une NPC au dossier n était pas associée de façon significative à la mortalité. Les taux de mortalité au sein de la cohorte appariée (n = 1078) étaient également similaires entre les patients avec NPC et ceux sans NPC : respectivement 89/333 (26,7 %) et 226/745 (30,3 %) (p = 0,23); la présence d une NPC n a pas été associée de façon significative à la mortalité après ajustements pour les facteurs de confusion potentiels. 212 C J H P Vol. 66, No. 4 July August 2013
2 Can J Hosp Pharm. 2013;66(4):212-8 Conclusion : La consignation des activités de pharmacie clinique est essentielle à l évaluation de l influence des pharmaciens sur les résultats cliniques pour les patients. Ces données suggèrent que les pharmaciens des USI accordent la priorité aux activités cliniques destinées aux soins des patients les plus malades. Mots clés : pharmacie clinique, consignation, résultats thérapeutiques, interventions, mortalité, durée du séjour [Traduction par l éditeur] INTRODUCTION Although the concept of clinical pharmacy emerged in the late 1960s, there followed a period of at least 40 years during which pharmacy practice saw few changes relative to the progress that has taken place recently. 1 Today, clinical pharmacy services are recognized for their significant contributions to optimal delivery of patient-centred care. In the intensive care unit (ICU), clinical pharmacists have established an indispensable role as part of the multidisciplinary health care team. 2,3 Nonetheless, as health care and pharmacy services continue to change, it becomes crucial to evaluate if a given practice is achieving the primary goal of improving patient outcomes. Documentation and analytical methods are necessary to assess whether patients are benefiting from various clinical services, particularly in the ICU, where a greater level of care is often required. Such knowledge can guide decision-making for future practice and assist in the provision of optimal patient care. Under the Health Professions Act of British Columbia, 4 as well as similar requirements set by pharmacy associations, a pharmacist s activities should be documented directly in the health care record. More specifically, the BC bylaw states that information on drug-related problems, recommendations, consultations, counselling, and clarifications should be part of the patient s permanent health care record. 4 There is no exception to this requirement in the ICU, where clinically important notes covering consultation requests, drug information responses, allergy history, drug therapy plans, and medication changes are to be documented directly in the patient s chart to improve continuity of care and accountability. In general practice, drug-related problems are prioritized and documented according to their potential to cause significant decline in the patient s condition. At the Royal Columbian Hospital (RCH) in New Westminster, British Columbia, all ICU patients are reviewed, but pharmacists generally provide documentation and devote more time to patients who are sicker or who have more acute conditions and those admitted more recently, because these patients are more likely to have active drugrelated problems. Such documentation can be used for quality assurance and to satisfy Canadian accreditation requirements. Documenting directly in the health care record avoids duplication and makes the process more efficient. In 1995, an innovative system was developed at RCH that enabled efficient documentation and measurement of pharmaceutical care activities. Together with the RCH Health Records Department, Gordon and others 5 established a process that involved pharmacists writing a clinical pharmacy note (CPN) in the patient s chart for each intervention, with each CPN being coded with the pharmacist s identity, ward number, and intervention type. The documentation process used by Gordon and others 5 was based on the abstracting system of the Health Records Department, which involves retrieval of specific information from patients charts. The information is entered into an electronic database; at the time of discharge, information in the database is used to generate a synopsis of the patient s admission, in a format suitable for analysis. Gordon and others 5 found that using the services of the Health Records Department not only helped to eliminate bias, but also resulted in more accurate reporting than would have been possible using information provided by the pharmacy department. By examining how pharmacy services affect outcomes such as cost, mortality, and length of stay, Bond and others 6 showed that as clinical pharmacist staffing levels increase, hospital mortality rate declines. However, few studies have evaluated pharmacist interventions in the ICU or examined the effects of clinical pharmacy services on hard clinical outcomes (such as mortality) directly reflecting tangible benefits to patients. The objective of the study reported here was to use the unique documentation system established at the RCH to evaluate the association between ICU patients severity of illness and clinical pharmacists interventions, and to compare mortality rates for patients with and without documented clinical pharmacy interventions. It was anticipated that the findings of this study would assist in the assignment of workload and the allocation of health care resources, as well as informing future research on clinical pharmacy services. C J H P Vol. 66, No. 4 July August
3 METHODS This observational study was conducted using inpatient data collected through the Health Records Department at RCH. Between 2004 and 2006, the adult ICU at this institution had 13 beds, and an additional bed was added in Although the ward was an adult ICU, adult-sized adolescents were occasionally admitted. The main study cohort comprised all patients with one or more ICU stays between January 1, 2004, and March 31, Patients were classified into 2 groups by the presence or absence of one or more CPNs recorded in the inpatient record during the ICU admission ( CPN group and no-cpn group, respectively). In this study, the presence of a CPN was used as an indicator of clinical pharmacist interventions. The Health Records Department was able to use the ward location in the CPN code to specifically select CPNs that had been written in the ICU. CPN codes specifically captured clinical interventions; interventions not requiring cognitive assessment, such as automatic drug substitutions, would not be captured through these codes. Any notes written by pharmacy students were reviewed and coded along with the pharmacist preceptor s name. At the RCH, CPNs are used to document clinical activities such as medication therapy recommendations and clinical pharmacist interventions intended to optimize a patient s drug therapy. More specifically, these activities and interventions may include provision of drug information, medication reconciliation at the time of admission, reporting of adverse drug reactions, clarifications of allergy history, and other clinical activities relevant to the identification and resolution of drug-related problems. Over the study period, all ICU patients, regardless of CPN status, were reviewed daily by ICU pharmacists during rounds. The hospital dispensary provided only minimal clinical support when ICU pharmacists were on site; instead, any potential drug-related issues identified in the dispensary would be brought to the attention of the ICU pharmacists for resolution. Although patients without CPNs would have received full rounds attendance in the ICU, those with CPNs would have received more in-depth review of their drug therapy by ICU pharmacists because of their medical status or the severity of their drug-related problems. For each patient, the Health Records Department assigned a complexity level on the basis of medical conditions present during the hospital stay, in accordance with the Canadian Institute for Health Information grouping methodology. The complexity or severity of illness ranged from 1 to 4, as defined in Appendix 1. The variables in the data set included age, sex, complexity level, ICU length of stay (days), hospital length of stay (days), a dichotomous indicator for the outcome of death before discharge, and a dichotomous indicator for the presence of one or more CPNs in a patient s record (see Appendix 1). For patients with multiple ICU admissions during a single hospital stay, the ICU length of stay was defined as the sum of ICU admissions. Characteristics of patients in the CPN and no-cpn groups were compared using descriptive statistics. Because CPN was not a randomly assigned intervention in this study, multivariate logistic regression modelling was performed to control for potential confounding in the following evaluations. 7 In the primary analysis, the association between complexity level (an ordinal explanatory variable) and CPN status (the outcome variable) was evaluated. The possible association between CPN status and mortality was also explored, first with the 2 test (2-sided level 0.05) and then with logistic regression to adjust for potential confounding. The mortality analysis was also carried out in a matched analysis, in which the CPN and no-cpn groups were matched by complexity level, a predictor of mortality. The matched cohort included all patients in the CPN group and a subset of patients from the no-cpn group, randomly selected to match the proportion of patients in each complexity level in the CPN group. All data analyses were conducted using SPSS version 20 (Chicago, Illinois). RESULTS The main study cohort had a total of 1561 patients: 333 (21.3%) patients with CPNs and 1228 (78.7%) with no CPNs. Mean age and sex ratio did not differ significantly between the 2 groups (Table 1). However, the groups did differ in the distribution of complexity levels (p < 0.001), with a greater proportion of patients in the CPN group than in the no-cpn group having complexity level 4, with potentially lifethreatening illnesses (295/333 [88.6%] and 660/1228 [53.7%], respectively). In contrast, a smaller proportion of patients in the CPN group than in the no-cpn group had complexity level 1, the lowest level of complexity (9/333 [2.7%] and 202/1228 [16.4%], respectively). Both ICU and hospital lengths of stay were significantly longer for patients in the CPN group (p < 0.001; Table 1). The mean difference in ICU length of stay was 14.1 days (95% confidence interval [CI] days), and the mean difference in hospital length of stay was 22.9 days (95% CI days). There was a significant association between complexity level and CPN status. After adjustment for age and sex, the odds ratio for presence of a CPN among patients with complexity level 4 (relative to patients with lower complexity levels) was 8.20 (95% CI ). The mortality rates in the 2 groups were not significantly different: 26.7% (89/333) among patients with CPNs and 27.9% (343/1228) among those with no CPNs (p = 0.66) (Table 2). Univariate regression analysis showed that CPN status was not associated with mortality rate, and the crude odds ratio (OR) for CPN versus 214 C J H P Vol. 66, No. 4 July August 2013
4 Table 1. Characteristics of Patients with and without Clinical Pharmacy Notes (CPNs) Characteristic CPN (n = 333) No CPN (n = 1228) p value Age (years), mean ± SD 57.2 ± ± Sex, no. (%) female 119 (35.7) 428 (34.9) 0.77 Complexity level < (2.7) 202 (16.4) 2 5 (1.5) 125 (10.2) 3 13 (3.9) 166 (13.5) (88.6) 660 (53.7) 9 11 (3.3) 75 (6.1) Length of stay (days), mean ± SD In ICU 19.8 ± ± 7.5 <0.001 In hospital 47.1 ± ± 35.5 <0.001 CPN = clinical pharmacy note present in patient chart, no CPN = no clinical pharmacy note in patient chart, SD = standard deviation. Table 2. Mortality Rate Subgroup No. (%) of Patients Who Died p Value CPN No CPN Full cohort (n = 1561) 89/333 (26.7) 343/1228 (27.9) 0.66 Matched cohort 89/333 (26.7) 226/745 (30.3) 0.23 (n = 1078) CPN = clinical pharmacy note present in patient chart; no CPN = no clinical pharmacy note in patient chart. no CPN was 0.94 (95% CI ). After adjustment for age, sex, complexity level, and length of stay in the ICU, the presence of a CPN remained not significantly associated with mortality (OR 0.86, 95% CI ). Alternative models were constructed to examine the effect of different model inputs. In all iterations, CPN was not significantly associated with mortality. In the matched analysis, the cohort (n = 1078) consisted of the 333 patients in the CPN group and 745 randomly selected patients from the no-cpn group. In the matched cohort, the mortality rates were 26.7% (89/333) in the CPN group and 30.3% (226/745) in the no-cpn group (p = 0.23) (Table 2). The CPN variable was not significantly associated with mortality after adjustment for age, sex, complexity level, or ICU length of stay in the regression analysis for the matched cohort. DISCUSSION Using a unique documentation system established at the RCH, we described the characteristics of ICU patients who had clinical pharmacist interventions, evaluated the association between complexity level and CPN status, and assessed the possible impact of clinical pharmacy interventions on mortality rate over a 39-month period. Given the critical care setting of this study, the majority of patients in the main cohort had complexity level 4 (61.2%), with potentially life-threatening illnesses. Conversely, the majority of patients had no CPNs (78.7%), most likely as a result of limited clinical pharmacist staffing and high work volume. Notably, however, patients with complexity level 4 constituted 88.6% of the CPN group but only 53.7% of the no-cpn group. This finding appears to indicate that pharmacists selectively provided interventions to sicker patients in their routine clinical practice. Indeed, there was a statistically significant association between complexity level 4 and CPN status. In this study, the odds of a CPN being present in the chart among patients with complexity level 4 was approximately 8 times the odds among patients with lower complexity levels. This association persisted after adjustment for age and sex. The observed association between complexity and CPN status suggested that the clinical pharmacists prioritized services and documentation for sicker patients. The CPN group had significantly longer lengths of stay in the ICU and in hospital than the no-cpn group. Since CPNs represent clinical pharmacy interventions and preceded discharge from both the ICU and the hospital, the length-ofstay measures were potential outcomes of the CPNs. However, patients with a longer length of stay may have had a greater likelihood of a CPN being recorded in the chart, relative to those with a shorter length of stay, because of an increased chance that new or additional drug-related problems would be identified during a longer stay. It is also possible that longer (eventual) lengths of stay reflected severe illness during the hospital stay (i.e., higher complexity level) which, as discussed C J H P Vol. 66, No. 4 July August
5 above, might have prompted intervention by a pharmacist and hence the recording of a CPN. It is unlikely that pharmacists saw patients only after they had been admitted for a period of time (as opposed to soon after admission), as newly admitted patients and those with more acute conditions tend to have more active drug-related problems, which would prompt the involvement of a clinical pharmacist. Although the CPN group presumably received more in-depth review of their drug therapy because of their medical status or severity of drug-related problems, all patients were assessed by ICU pharmacists, irrespective of CPN status. Previous authors who evaluated length of stay, including Bjornson and others, 8 have found that clinical pharmacy interventions (medication reconciliation, drug therapy plans, and discharge counselling) decreased the length of stay among patients in the intervention group. Similarly, Boyko and others 9 showed that length of stay was reduced when clinical pharmacists were incorporated into general medical teams. This evidence, which contrasts with the findings of the current study, supports reductions in length of stay in association with clinical pharmacy interventions. In this small cohort of 1561 patients, the presence of CPNs was not associated with a lower mortality rate. The effect of CPN on mortality was not statistically significant after adjustment for age, sex, level of complexity, and length of stay in the ICU. The effect was also not significant after the CPN and no-cpn groups were matched by complexity level, a predictor of mortality. These findings may have been limited by the small cohort size and the possible influence of unmeasured or inadequately controlled confounding, rather than a lack of impact. Furthermore, inaccuracies in data abstracting and miscoding were possible sources of error that could not be quantified. Although errors in data abstracting were assumed to be minimal, some clinical pharmacist interventions might not have been recorded if CPN codes were missing (e.g., for interventions performed by newly employed clinical pharmacists who had not yet been assigned a pharmacist code or in cases when clinical pharmacists neglected to document a CPN code in the chart). Such errors would have led to underreporting of interventions captured as CPNs and misclassification of patients. Moreover, the presence of a CPN might not have reflected the full scope of clinical pharmacist interventions in the ICU. Further research is needed to identify methods to accurately measure clinical pharmacist interventions in the ICU and to evaluate the effect of various types of intervention on clinical outcomes. Many of the studies examining pharmacist interventions have had small sample sizes from one or only a few sites, short durations, and several uncontrolled confounding factors. The lack of consistency in methodology for evaluating interventions leads to difficulty in comparing study results. In turn, conflicting results in the literature make it difficult to draw conclusions on the impact of clinical pharmacy interventions. In their systematic review, Kaboli and others 10 searched for literature regarding the effects of clinical pharmacy interventions on processes and outcomes. They found that in-hospital mortality rate had been analyzed in 8 of the 36 trials included in the review, and only one of these trials, involving an antimicrobial control program, 11 demonstrated a statistically significant reduction in mortality; of the remaining 7 trials, 3 showed a lower mortality rate and 4 had higher mortality rates with pharmacy interventions, but these findings were not statistically significant. 10 With such limited evidence and the tendency for trials to evaluate interventions in only one specific area of practice (e.g., renal monitoring or antimicrobial monitoring), determining where and to what extent patients benefit from clinical pharmacy interventions remains unclear. Bond and Raehl 12 recognized that large trials are needed to help develop clinical pharmacy practice and to reduce the potential bias associated with small, single-site studies. Using records from 1998, they analyzed data for patients at 885 hospitals in the United States. In contrast to the results reported here, they found that half (7) of the 14 pharmacy services examined (drug-use evaluation, in-service education, management of adverse drug reactions, management of drug protocol, participation on cardiopulmonary resuscitation teams, participation on medical rounds, and admission drug histories) were associated with lower mortality rates. 12 However, their analysis considered only overall hospital mortality rate. Studies examining mortality in the ICU remain scarce. MacLaren and Bond 13 were the first to demonstrate lower mortality rate, shorter length of stay in the ICU, and lower costs when clinical pharmacists were directly involved in the care of ICU patients with thromboembolic or infarction-related events. They retrieved data from a large database of patients, 13 but, like the work of Bond and Raehl, 12 their analysis was limited to correlating mortality rate with clinical pharmacy services. They did not account for numerous additional factors that may affect mortality rate, which makes it difficult to determine whether the presence of these services truly had an effect on overall mortality rate. Moreover, they evaluated outcomes only for a specific patient population within the ICU. In the current study, we used CPNs as recorded in administrative data as an indicator of pharmacists interventions and evaluated the clinical effect of CPNs at the individual patient level, under routine clinical practice conditions. This methodology can be adapted to clarify how pharmacists affect patient care in many clinical settings. The current study had several limitations. First, the sample size was too small to detect a statistically significant difference in mortality. Although data for this patient population were collected beyond March 31, 2007, and inclusion of more recent data would have expanded the sample size, only C J H P Vol. 66, No. 4 July August 2013
6 consecutive years of data were analyzed because the abstracting software used by the Health Records Department was changed in Future studies could analyze data from 2008 and beyond, to expand the sample size and study duration. Furthermore, it is possible that not all interventions performed by clinical pharmacists were captured with CPNs. In practice, CPNs are often written to document drug kinetics, consultations, and clinically significant drug interactions. However, patients without documented CPNs might have received verbal recommendations or consultations from clinical pharmacists; in addition, regardless of CPN status, all patients were reviewed by ICU pharmacists. Basing the intervention tally only on documented interventions may have led to underestimation of the number of patients who received interventions and inclusion in the no-cpn group of patients for whom a pharmacist performed an intervention. As such, the results of this study may have been biased toward no effect, and the true impact of clinical pharmacy interventions may be greater than what was shown in this study. The analyses were also restricted to a single study site, because the study was based on the unique documentation system previously established at this hospital by Gordon and others. 5 This may limit the generalizability of these results to other ICUs. The outcomes of some patients may have been misclassified, including those of patients discharged to other institutions or facilities. For example, if a patient was transferred to the ICU of another institution, the length of ICU stay recorded for this study would have been limited to data available in records at the study hospital and would not have included time in any other ICU. Although the coding system used by the Health Records Department documents the intervention type and the total number of CPNs recorded for each patient, this study did not evaluate these variables. Other clinically relevant data, such as Acute Physiology and Chronic Health Evaluation (APACHE) scores and rates of ventilator-associated pneumonia, were also not included in the study. These parameters may be useful in future studies to identify specific patient groups that may require more clinical pharmacy services and clinical activities with greater impact, as well as to describe the types of interventions that pharmacists are performing. This information might assist in identifying patient populations or service areas where increased staffing or emphasis from clinical pharmacists could have a greater impact on patient care. Documentation of pharmacy activities is an important component of clinical pharmacy practice. Together with the results of the previous study, 5 this study has demonstrated that an established coding system for CPNs can be used to create a database suitable for analysis to evaluate the impact of clinical pharmacy services on various patient outcomes. Although this study showed no significant impact of CPNs on mortality rates in the ICU, future studies incorporating larger sample sizes, longer study periods, and multiple study sites might demonstrate significant differences in mortality rates and other outcomes. This process can be an effective tool for assisting with workload distribution, ensuring pharmacist accountability, and improving clinical practice. As clinical pharmacy continues to evolve and services continue to expand, this relatively new aspect of health care will require similar investigations to establish the role of clinical pharmacy practice and to maximize its positive impact on patient outcomes. CONCLUSIONS The documentation of clinical pharmacy activities and the ability to identify pharmacists interventions in electronic health records are essential for assessing pharmacists impact on patient outcomes. In this observational study, we found that pharmacists provided more in-depth care to patients with higher complexity levels, as evidenced by documentation of important information regarding drug-related problems. However, pharmacists interventions as documented in inpatient records were not associated with mortality rate. Further investigations are needed to more accurately measure the clinical impact of pharmacist services and to identify the types of interventions most beneficial to ICU patients. References 1. Miller RR. History of clinical pharmacy and clinical pharmacology. J Clin Pharmacol. 1981;21(4): Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3): Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64(23): Health Professions Act bylaws. Schedule F, Part 2. Hospital pharmacy standards of practice. Vancouver (BC): College of Pharmacists of British Columbia; 2010 [cited 2012 Apr 27]. Available from: bcpharmacists.org/d-legislation_standards/d-2_provincial_legislation/ 5079-HPA_Bylaws_Hospital.pdf 5. Gordon W, Malyuk D, Taki J. Use of health-record abstracting to document pharmaceutical care activities. Can J Hosp Pharm. 2000;53(3): Bond CA, Raehl CL, Pitterle ME, Franke T. Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy. 1999;19(2): Wunsch H, Linde-Zwirble WT, Angus DC. Methods to adjust for bias and confounding in critical care health services research involving observational data. J Crit Care. 2006;21(1): Bjornson DC, Hiner WO Jr, Potyk RP, Nelson BA, Lombardo FA, Morton TA, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50(9): Boyko WL, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997;54(14): Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006; 166(9): Gentry CA, Greenfield RA, Slater LN, Wack M, Huycke MM. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm. 2000;57(3): C J H P Vol. 66, No. 4 July August
7 12. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4): MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009;29(7): Claudia K Ho, BSc(Pharm), is a Clinical Pharmacy Resident, Lower Mainland Pharmacy Services at Fraser Health, Vancouver, British Columbia. Vincent H Mabasa, BSc(Pharm), ACPR, PharmD, is Coordinator, Clinical Pharmacy Services, at the Burnaby Hospital, Burnaby, British Columbia. Vivian W Y Leung, BSc(Pharm), ACPR, PharmD, is a PhD candidate at the University of British Columbia, Vancouver, British Columbia. Douglas L Malyuk, BSc(Pharm), ACPR, PharmD, is a Clinical Pharmacy Specialist Intensive Care, at the Royal Columbian Hospital, New Westminster, British Columbia. Jerrold L Perrott, BSc(Pharm), ACPR, PharmD, is a Clinical Pharmacy Specialist Intensive Care, at the Royal Columbian Hospital, New Westminster, British Columbia. Competing interests: None declared. Address correspondence to: Dr Vincent H Mabasa Burnaby Hospital 3935 Kincaid Street Burnaby BC V5G 2X6 Vincent.Mabasa@fraserhealth.ca Appendix 1. Definitions for the data set categories obtained from the Health Records Department Data Type Length of stay Complexity level Clinical pharmacy note status Discharge date ICU stay ICU admission date ICU discharge date ICU days Status of expiry ICU = intensive care unit. Definition Number of days a patient stayed in hospital for a specific admission. Levels of severity or complexity of disease or condition as determined by Health Records Department s standard evaluation procedure: 1. No complexity 2. Complexity related to chronic condition(s) 3. Complexity related to serious/important condition(s) 4. Complexity related to potentially life-threatening condition(s) 9. Complexity not applied (maternity, newborn, psychiatry, HIV, some trauma cases) Note that is written in the patient s chart by a pharmacist, often in the form of a SOAP note (subjective, objective, assessment, plan); may contain various types of information, but primarily recommendations for resolution of drug-related problems. Date that the patient was discharged with approval (including transfer to another facility). Admission date and time the patient entered the ICU. Discharge date and time the patient left the ICU. Total number of days the patient stayed in the ICU; minimum stay is counted as 1 day, even if the ICU visit started and ended on the same calendar day. Expired patients refers to those who died during the hospital admission. 218 C J H P Vol. 66, No. 4 July August 2013
Development and Initial Evaluation of a Software-Based Clinical Workload Measurement System for Pharmacists
ARTICLE Development and Initial Evaluation of a Software-Based Clinical Workload Measurement System for Pharmacists Adrienne J Lindblad, Alison Alleyne, and Jason Howorko ABSTRACT Background: Implementation
More informationHospital pharmacists play an important role in improving
CLINICAL PRACTICE The Invisible White Coat: Awareness of Pharmacists in a Neonatal Intensive Care Unit Rehana Bajwa, Jennifer G Kendrick, and Roxane Carr NTRODUCTION Hospital pharmacists play an important
More informationHospitals organize medications according to a formulary
INNOVATIONS IN PHARMACY PRACTICE: CLINICAL PRACTICE Going through the Motions: A Time-and- Motion Study of Workload Associated with Nonformulary Medication Orders Elaine Chang, Angus Kinkade, Anthony C
More informationPerformance Measurement of a Pharmacist-Directed Anticoagulation Management Service
Hospital Pharmacy Volume 36, Number 11, pp 1164 1169 2001 Facts and Comparisons PEER-REVIEWED ARTICLE Performance Measurement of a Pharmacist-Directed Anticoagulation Management Service Jon C. Schommer,
More informationW e were aware that optimising medication management
207 QUALITY IMPROVEMENT REPORT Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds M Fertleman, N Barnett, T Patel... See end of article for authors affiliations...
More informationManaging Medications and QMENTUM: Can We Measure Up?
Managing Medications and QMENTUM: Can We Measure Up? Neil J. M ac Kinnon, Ph.D., FCSHP Associate Professor & Associate Director for Research Dalhousie University College of Pharmacy A presentation about
More informationPatient Satisfaction with Antituberculosis Medication Counselling: A Comparison of Services Provided by Pharmacists and Nurses
ARTICLE Patient Satisfaction with Antituberculosis Medication Counselling: A Comparison of Services Provided by Pharmacists and Nurses Susanne Moadebi, Greg Stark, R. Kevin Elwood, Rick White, and Fawziah
More informationUsing Data to Inform Quality Improvement
20 15 10 5 0 Using Data to Inform Quality Improvement Ethan Kuperman, MD FHM Aparna Kamath, MD MS Justin Glasgow, MD PhD Disclosures None of the presenters today have relevant personal or financial conflicts
More informationDo we need a pharmacist in the ICU?
Intensive Care Med (2015) 41:1314 1320 DOI 10.1007/s00134-015-3718-0 EDITORIAL Clarence Chant Norman F. Dewhurst Jan O. Friedrich Do we need a pharmacist in the ICU? Received: 13 February 2015 Accepted:
More informationCanadian Major Trauma Cohort Research Program
Canadian Major Trauma Cohort Research Program March 2006 John S. Sampalis, PhD Funding Provided by: Canadian Health Services Research Foundation National Trauma Registry Quebec Trauma Registry Fonds de
More informationDisclosure. SwedishAmerican Hospital A Division of UW Health. Learning Objectives. Medication History. Medication History 2/2/2017
Disclosure Pharmacy Technician- Acquired Medication Histories in the ED: A Path to Higher Quality of Care David Huhtelin, PharmD Emergency Medicine Clinical Pharmacist SwedishAmerican Hospital A Division
More informationPatients Hospitalized for Medical Conditions in Winnipeg, Canada: Appropriateness and Level of Care
Patients Hospitalized for Medical Conditions in Winnipeg, Canada: Appropriateness and Level of Care by Sharon Bruce, Carolyn DeCoster, Jan Trumble-Waddell and Charles Burchill Introduction Sharon Bruce
More informationDuring the past few decades,
Practice report Clinical pharmacy interventions P R A C t i c e R e P O R T Economic effects of clinical pharmacy interventions: A literature review Thomas De Rijdt, Ludo Willems, and Steven Simoens During
More informationBurnout in ICU caregivers: A multicenter study of factors associated to centers
Burnout in ICU caregivers: A multicenter study of factors associated to centers Paolo Merlani, Mélanie Verdon, Adrian Businger, Guido Domenighetti, Hans Pargger, Bara Ricou and the STRESI+ group Online
More information4/26/2017. Emergency Department Pharmacist Interventions in a Small, Rural Hospital. Disclosure Statement. Learning Objectives
Emergency Department Pharmacist Interventions in a Small, Rural Hospital Chaundra Sewell, PharmD PGY1 Pharmacy Practice Resident Community Medical Center Missoula, MT Disclosure Statement This presenter
More informationThe number of patients admitted to acute care hospitals
Hospitalist Organizational Structures in the Baltimore-Washington Area and Outcomes: A Descriptive Study Christine Soong, MD, James A. Welker, DO, and Scott M. Wright, MD Abstract Background: Hospitalist
More informationEXPERIENTIAL EDUCATION Medication Therapy Management Services Provided by Student Pharmacists
EXPERIENTIAL EDUCATION Medication Therapy Management Services Provided by Student Pharmacists Micah Hata, PharmD, a Roger Klotz, BSPharm, a Rick Sylvies, PharmD, b Karl Hess, PharmD, a Emmanuelle Schwartzman,
More informationBruce Cload, MD, PhD Andrew G. Day, MSc Roy Ilan, MD
Can J Anesth/J Can Anesth (2010) 57:830 835 DOI 10.1007/s12630-010-9348-7 REPORTS OF ORIGINAL INVESTIGATIONS Evaluation of unnecessary central venous catheters in critically ill patients: a prospective
More informationReducing Interprofessional Conflicts in Order to Facilitate Better Rural Care: A Report From a 2016 Rural Surgical Network Invitational Meeting
Reducing Interprofessional Conflicts in Order to Facilitate Better Rural Care: A Report From a 2016 Rural Surgical Network Invitational Meeting Hayley PELLETIER* 1 1 Student, University of British Columbia,
More informationSupplementary Online Content
Supplementary Online Content Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.
More informationFrequently Asked Questions (FAQ) Updated September 2007
Frequently Asked Questions (FAQ) Updated September 2007 This document answers the most frequently asked questions posed by participating organizations since the first HSMR reports were sent. The questions
More informationJournal of Pharmacy Practice and Community Medicine.2017, 3(4s):S95-S100
Journal of Pharmacy Practice and Community Medicine.2017, 3(4s):S95-S100 http://dx.doi.org/10.5530/jppcm.2017.4s.55 RESEARCH ARTICLE OPEN ACCESS Pharmacy Technician Workload and Workforce Requirements
More informationTrends in use in a Canadian pediatric emergency department
ORIGINAL RESEARCH N RECHERCHE ORIGINALE Trends in use in a Canadian pediatric emergency department Quynh Doan, MDCM, MHSc, PhD* 3 ; Emerson D. Genuis, MD 3 ; Alvis Yu ABSTRACT Introduction: Emergency department
More informationThe Determinants of Patient Satisfaction in the United States
The Determinants of Patient Satisfaction in the United States Nikhil Porecha The College of New Jersey 5 April 2016 Dr. Donka Mirtcheva Abstract Hospitals and other healthcare facilities face a problem
More informationMedication Reconciliation
Medication Reconciliation Where are we now? Angie Powell, PharmD Director of Pharmacy Baxter Regional Medical Center Disclosures I, Angie Powell, have no relevant financial relationships to disclose. Learning
More informationMissed Opportunity: Patients Who Leave Emergency Departments without Being Seen
DATA MATTERS Missed Opportunity: Patients Who Leave Emergency Departments without Being Seen Occasions manquées : les patients qui repartent des services d urgence sans avoir été examinés by AKERKE BA
More informationBringing the Clinical Mindset to the Retail Pharmacist
Bringing the Clinical Mindset to the Retail Pharmacist Sarah Griffin, Pharm.D. Harding University College of Pharmacy White County Medical Center Objectives Describe challenging situations faced by pharmacists
More informationCause of death in intensive care patients within 2 years of discharge from hospital
Cause of death in intensive care patients within 2 years of discharge from hospital Peter R Hicks and Diane M Mackle Understanding of intensive care outcomes has moved from focusing on intensive care unit
More informationScottish Hospital Standardised Mortality Ratio (HSMR)
` 2016 Scottish Hospital Standardised Mortality Ratio (HSMR) Methodology & Specification Document Page 1 of 14 Document Control Version 0.1 Date Issued July 2016 Author(s) Quality Indicators Team Comments
More informationThe impact of nighttime intensivists on medical intensive care unit infection-related indicators
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2016 The impact of nighttime intensivists on medical intensive care unit infection-related indicators Abhaya Trivedi
More informationComparison on Human Resource Requirement between Manual and Automated Dispensing Systems
VALUE IN HEALTH REGIONAL ISSUES 12C (2017) 107 111 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/vhri Comparison on Human Resource Requirement between Manual and Automated
More informationThe impact of an ICU liaison nurse service on patient outcomes
The impact of an ICU liaison nurse service on patient outcomes Suzanne J Eliott, David Ernest, Andrea G Doric, Karen N Page, Linda J Worrall-Carter, Lukman Thalib and Wendy Chaboyer Increasing interest
More informationThe Pharmacist Coalition for Health Reform
1 As Australian health professionals and policymakers grapple with the pressures and realities of caring for a growing community with changing needs, there s an opportunity to uncover better ways of using
More informationCLINICAL PREDICTORS OF DURATION OF MECHANICAL VENTILATION IN THE ICU. Jessica Spence, BMR(OT), BSc(Med), MD PGY2 Anesthesia
CLINICAL PREDICTORS OF DURATION OF MECHANICAL VENTILATION IN THE ICU Jessica Spence, BMR(OT), BSc(Med), MD PGY2 Anesthesia OBJECTIVES To discuss some of the factors that may predict duration of invasive
More informationThe labour partogramme has been heralded as
Original Article A SURVEY OF THE KNOWLEDGE, ATTITUDE AND PRACTICE OF THE LABOUR PARTOGRAMME AMONG HEALTH PERSONNEL IN SEVEN PERIPHERAL HOSPITALS IN YAOUNDE, CAMEROON. DOHBIT J.S.¹; NANA N.P. 2 ; FOUMANE
More informationResearcher: Dr Graeme Duke Software and analysis assistance: Dr. David Cook. The Northern Clinical Research Centre
Real-time monitoring of hospital performance: A practical application of the hospital and critical care outcome prediction equations (HOPE & COPE) for monitoring clinical performance in acute hospitals.
More informationJournal of Pharmacy Practice and Community Medicine.2017, 3(4s):S61-S66
Journal of Pharmacy Practice and Community Medicine.2017, 3(4s):S61-S66 http://dx.doi.org/10.5530/jppcm.2017.4s.50 RESEARCH ARTICLE OPEN ACCESS Pharmacy Workload and Workforce Requirements at MOH Primary
More informationUsing the job characteristics model to compare patient care assignment methods of nurses A.H. Mohamed 1
Eastern Mediterranean Health Journal, Vol. 10, No. 3, 2004 389 Using the job characteristics model to compare patient care assignment methods of nurses A.H. Mohamed 1 ABSTRACT The aim of this study was
More informationTelephone triage systems in UK general practice:
Research Tim A Holt, Emily Fletcher, Fiona Warren, Suzanne Richards, Chris Salisbury, Raff Calitri, Colin Green, Rod Taylor, David A Richards, Anna Varley and John Campbell Telephone triage systems in
More informationWho Cares About Medication Reconciliation? American Pharmacists Association American Society of Health-system Pharmacists The Joint Commission Agency
The Impact of Medication Reconciliation Jeffrey W. Gower Pharmacy Resident Saint Alphonsus Regional Medical Center Objectives Understand the definition and components of effective medication reconciliation
More information17 Inpatient satisfaction with physician.pmd 358. services at King Khalid University Hospital, Riyadh, Saudi Arabia A.H.
358 La Revue de Santé de la Méditerranée orientale, Vol. 10, N o 3, 2004 Inpatient satisfaction with physician services at King Khalid University Hospital, Riyadh, Saudi Arabia A.H. Al-Doghaither 1 ABSTRACT
More informationEpidemiological approach to nosocomial infection surveillance data: the Japanese Nosocomial Infection Surveillance System
Environ Health Prev Med (2008) 13:30 35 DOI 10.1007/s12199-007-0004-y REVIEW Epidemiological approach to nosocomial infection surveillance data: the Japanese Nosocomial Infection Surveillance System Machi
More informationA Comparison of Job Responsibility and Activities between Registered Dietitians with a Bachelor's Degree and Those with a Master's Degree
Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 11-17-2010 A Comparison of Job Responsibility and Activities between Registered Dietitians
More informationPharmaceutical Care A case study of Connaught Hospital
International Journal of Scientific and Research Publications, Volume 7, Issue 7, July 2017 731 Pharmaceutical Care A case study of Connaught Hospital Brian S. Thompson *, Prof. A.C Oparah ** * Dept. of
More informationAddressing Cost Barriers to Medications: A Survey of Patients Requesting Financial Assistance
http://www.ajmc.com/journals/issue/2014/2014 vol20 n12/addressing cost barriers to medications asurvey of patients requesting financial assistance Addressing Cost Barriers to Medications: A Survey of Patients
More informationQuantifying the Impact of Prescription-Related Problems on Pharmacy Workload
ARTICLE Quantifying the Impact of Prescription-Related Problems on Pharmacy Workload Mark Fok and Angela Lo ABSTRACT Objectives: To determine pharmacy workload related to resolving prescription-related
More informationOccupational stress and workrelated unintentional injuries among Iranian car manufacturing workers H. Soori, 1 M. Rahimi 2 and H.
Eastern Mediterranean Health Journal, Vol. 14, No. 3, 2008 697 Occupational stress and workrelated unintentional injuries among Iranian car manufacturing workers H. Soori, 1 M. Rahimi 2 and H. Mohseni
More informationSince 1979 a variety of medical classification standards have been used to collect
Medical classification systems in Canada: moving toward the year 2000 André N. Lalonde, MHA; Elizabeth Taylor Abstract THE USE OF DIFFERENT STANDARDS FOR CODING DIAGNOSES and procedures has been identified
More informationNurse-initiated, titrated intravenous opioid analgesia reduces time to analgesia for selected painful conditions
EM ADVANCES INNOVATIONS EN MU Nurse-initiated, titrated intravenous opioid analgesia reduces time to analgesia for selected painful conditions Anne-Maree Kelly, MD, MClinEd, FACEM; * Catherine Brumby;
More informationMethodology Notes. Cost of a Standard Hospital Stay: Appendices to Indicator Library
Methodology Notes Cost of a Standard Hospital Stay: Appendices to Indicator Library February 2018 Production of this document is made possible by financial contributions from Health Canada and provincial
More informationTransition hôpital-domicile: Risques et opportunités! Pr Martine LOUIS SIMONET Formation Continue Médecins de Famille Genève 14 avril 2016
Transition hôpital-domicile: Risques et opportunités! Pr Martine LOUIS SIMONET Formation Continue Médecins de Famille Genève 14 avril 2016 Transitional care is defined as a set of actions designed to ensure
More informationUNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM
BOARD OF PHARMACY SPECIALTIES CRITICAL CARE PHARMACY SPECIALIST CERTIFICATION CONTENT OUTLINE/CLASSIFICATION SYSTEM FINALIZED SEPTEMBER 2017/FOR USE ON FALL 2018 EXAMINATION AND FORWARD UNDERSTANDING THE
More informationMedication Reconciliation: Using Pharmacy Technicians to Improve Care. Becky Johnson, CPhT Megan Ohrlund, PharmD Steve Finch, RPh
Medication Reconciliation: Using Pharmacy Technicians to Improve Care Becky Johnson, CPhT Megan Ohrlund, PharmD Steve Finch, RPh Objectives Evaluate the medication reconciliation process and evidence for
More informationEvaluation of Booking Systems for Elective Surgery Using Simulation Experiments
RESEARCH PAPER Evaluation of Booking Systems for Elective Surgery Using Simulation Experiments Simulations expérimentales pour évaluer les systèmes de rendez-vous pour les chirurgies non urgentes by B
More informationMedication Reconciliation: Using Pharmacy Technicians to Improve Care. Objectives THE BASICS AND USING TECHNICIANS 3/22/2017
Medication Reconciliation: Using Pharmacy Technicians to Improve Care Becky Johnson, CPhT Megan Ohrlund, PharmD Steve Finch, RPh Objectives Evaluate the medication reconciliation process and evidence for
More informationDomiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis Tuggey J M, Plant P K, Elliott M W
Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis Tuggey J M, Plant P K, Elliott M W Record Status This is a critical abstract of an economic evaluation
More informationCanadian Consensus on Clinical Pharmacy Key Performance Indicators: Knowledge Mobilization Guide
Canadian Consensus on Clinical Pharmacy Key Performance Indicators: Knowledge Mobilization Guide MAKE IT COUNT! Advancing practice to improve patient outcomes AUTHORS Olavo Fernandes Kent Toombs Taciana
More informationDeterminants and Outcomes of Privately and Publicly Financed Home-Based Nursing
Determinants and Outcomes of Privately and Publicly Financed Home-Based Nursing Peter C. Coyte, PhD Denise Guerriere, PhD Patricia McKeever, PhD Funding Provided by: Canadian Health Services Research Foundation
More informationMedication Errors Assessment and Prevention by a Clinical Pharmacist in Pediatric Wards. Peshawar, KPK-Pakistan. Original Article.
Original Article Medication Errors Assessment and Prevention by a Clinical Pharmacist in Pediatric Wards of RMI Hospital Peshawar, KPK-Pakistan ABSTRACT Background: Medication errors are the most common
More informationPOLICY BRIEF. Identifying Adverse Drug Events in Rural Hospitals: An Eight-State Study. May rhrc.umn.edu. Background.
POLICY BRIEF Identifying Adverse Drug Events in Rural Hospitals: An Eight-State Study Michelle Casey, MS Peiyin Hung, MSPH Emma Distel, MPH Shailendra Prasad, MBBS, MPH Key Findings In 2013, Critical Access
More informationChallenges in Evaluating a Prototype Project in a Large Health Authority: Lessons Learned
Research and Practice Notes/Notes sur la recherche et les méthodes Challenges in Evaluating a Prototype Project in a Large Health Authority: Lessons Learned M. Elizabeth Snow Centre for Health Evaluation
More informationAcute Care Cardiology Learning Description at Emory University Hospital Midtown (EUHM)
Acute Care Cardiology Learning Description at Emory University Hospital Midtown (EUHM) Preceptor: Candace R. Stearns, PharmD, BCPS Office: EUHM, Peachtree Building, 2 nd floor, room 2182 Hours: ~ 7:30
More informationDANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017]
DANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017] A quality of care assessment comparing safety and efficacy of edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in patients
More informationComparative analysis of clinical pharmacy interventions in a pediatric intensive care unit
Original Crit Care Shock (2018) 21:7-14 Comparative analysis of clinical pharmacy interventions in a pediatric intensive care unit Joseph M LaRochelle, Kayrah Jack, Brent A Kitto, Aryn Karpinski, Amy M
More informationCost-Benefit Analysis of Medication Reconciliation Pharmacy Technician Pilot Final Report
Team 10 Med-List University of Michigan Health System Program and Operations Analysis Cost-Benefit Analysis of Medication Reconciliation Pharmacy Technician Pilot Final Report To: John Clark, PharmD, MS,
More informationSICU Curriculum for CA2 West Virginia University Department of Anesthesiology
SICU Curriculum for CA2 West Virginia University Department of Anesthesiology Description of Rotation or Educational Experience One month rotation in SICU as CA1 and another month in SICU as a CA2. During
More informationDeterminants of Unacceptable Waiting Times for Specialized Services in Canada
RESEARCH PAPER Determinants of Unacceptable Waiting Times for Specialized Services in Canada Facteurs déterminants des temps d attente inacceptables pour l obtention de services spécialisés au Canada by
More informationTC911 SERVICE COORDINATION PROGRAM
TC911 SERVICE COORDINATION PROGRAM ANALYSIS OF PROGRAM IMPACTS & SUSTAINABILITY CONDUCTED BY: Bill Wright, PhD Sarah Tran, MPH Jennifer Matson, MPH The Center for Outcomes Research & Education Providence
More informationNursing skill mix and staffing levels for safe patient care
EVIDENCE SERVICE Providing the best available knowledge about effective care Nursing skill mix and staffing levels for safe patient care RAPID APPRAISAL OF EVIDENCE, 19 March 2015 (Style 2, v1.0) Contents
More informationOrganizational and Professional Characteristics Predicting External Communications in Canadian Public Health Units
A B S T R A C T This study is a survey of administrative divisions involved in tobacco programs in Canadian public health units. It aims to identify correlates of public health units contacts and collaborations
More informationStudent Project PRACTICE-BASED RESEARCH
A Description of Medication Therapy Management Services in Minnesota Amie Jo Digatono, Pharm.D. Candidate, College of Pharmacy, University of Minnesota Key words: medication therapy management, Minnesota,
More informationPhysician Use of Advance Care Planning Discussions in a Diverse Hospitalized Population
J Immigrant Minority Health (2011) 13:620 624 DOI 10.1007/s10903-010-9361-5 BRIEF COMMUNICATION Physician Use of Advance Care Planning Discussions in a Diverse Hospitalized Population Sonali P. Kulkarni
More informationDirection du médicament. Sylvie Bouchard Director
Direction du médicament Sylvie Bouchard Director South America mission 28 November 2016 Aim of the presentation To present INESSS s mandates with regard to medication To explain the Régime d assurance
More informationNeurocritical Care Rotation - EUH
Preceptor: Bill Asbury, B.S., Pharm.D. Office: EUH- EG35 Hours: ~ 8:00am-4:30pm Desk: 404-712-7491 Pager: 404-686-5500 pic 14028 ICU cell phone: 404-326-8256 PGY-2 Residency Training Program Neurocritical
More informationMaking a case for medication reconciliation in primary care
Safer Healthcare Now! MedRec National Teleconference Making a case for medication reconciliation in primary care Speakers: Karen Hall Barber, BSc (Hons), MD, CCFP Sherri Elms, BSc (Pharm), RPh ACPR Danyal
More informationA SURVEY OF PHARMACY AND THERAPEUTIC COMMITTEES ACROSS CANADA: SCOPE AND RESPONSIBILITIES
A SURVEY OF PHARMACY AND THERAPEUTIC COMMITTEES ACROSS CANADA: SCOPE AND RESPONSIBILITIES Nicole Mittmann 1,2, Sandra Knowles 3 1 HOPE Research Centre, Division of Clinical Pharmacology, Sunnybrook Health
More informationAdvanced practice in emergency care: the paediatric flow nurse
Advanced practice in emergency care: the paediatric flow nurse Development and implementation of a new liaison role in paediatric services in Australia has improved services for children and young people
More informationAnalyzing Readmissions Patterns: Assessment of the LACE Tool Impact
Health Informatics Meets ehealth G. Schreier et al. (Eds.) 2016 The authors and IOS Press. This article is published online with Open Access by IOS Press and distributed under the terms of the Creative
More informationOntario s alternate funding arrangements for emergency departments: the impact on the emergency physician workforce
ED ADMINISTRATION L ADMINISTRATION DE LA MU Ontario s alternate funding arrangements for emergency departments: the impact on the emergency physician workforce Michael J. Schull, MD, MSc; * Marian Vermeulen,
More informationInformation systems with electronic
Technology Innovations IT Sophistication and Quality Measures in Nursing Homes Gregory L. Alexander, PhD, RN; and Richard Madsen, PhD Abstract This study explores relationships between current levels of
More informationProtocol. This trial protocol has been provided by the authors to give readers additional information about their work.
Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Kerlin MP, Small DS, Cooney E, et al. A randomized trial of nighttime
More informationChapter 39 Bed occupancy
National Institute for Health and Care Excellence Final Chapter 39 Bed occupancy Emergency and acute medical care in over 16s: service delivery and organisation NICE guideline 94 March 218 Developed by
More informationA physician workforce planning model applied to Canadian anesthesiology: planning the future supply of anesthesiologists
GENERAL ANESTHESIA 671 A physician workforce planning model applied to Canadian anesthesiology: planning the future supply of anesthesiologists [Un modèle de planification des effectifs médicaux appliqué
More informationChapter F - Human Resources
F - HUMAN RESOURCES MICHELE BABICH Human resource shortages are perhaps the most serious challenge fac Canada s healthcare system. In fact, the Health Council of Canada has stated without an appropriate
More informationAvailability of Healthcare Resources, Positive Ratings of the Care Experience and Extent of Service Use: An Unexpected Relationship
Research Paper Availability of Healthcare Resources, Positive Ratings of the Care Experience and Extent of Service Use: An Unexpected Relationship Disponibilité des ressources de soins de santé, appréciation
More informationWORKPLACE-RELATED BURNS
WORKPLACE-RELATED BURNS Mian M.A.H., 1 * Mullins R.F., 1,2,3 Alam B., 1 Brandigi C., 1,2,3 Friedman B.C., 1,3,4 Shaver J.R., 3,4 Hassan Z. 1,2,3 1 Joseph M. Still Research Foundation at Doctors Hospital,
More informationSuicide Among Veterans and Other Americans Office of Suicide Prevention
Suicide Among Veterans and Other Americans 21 214 Office of Suicide Prevention 3 August 216 Contents I. Introduction... 3 II. Executive Summary... 4 III. Background... 5 IV. Methodology... 5 V. Results
More informationHelping physicians care for patients Aider les médecins à prendre soin des patients
CMA s Response to Health Canada s Consultation Questions Regulatory Framework for the Mandatory Reporting of Adverse Drug Reactions and Medical Device Incidents by Provincial and Territorial Healthcare
More informationMedical Intensive Care Unit Rotation EUHM
PGY 2 Residency Training Program Medical Intensive Care Unit Rotation EUHM Preceptor: Derek M. Polly, PharmD Office: EUHM, 2 nd Floor, Room 2182 Hours: ~ 7:30 4:00 Desk: 404 686 5674 Pager: 404 686 5500
More informationHospital Mental Health Database, User Documentation
Hospital Mental Health Database, 2015 2016 User Documentation Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The
More informationPrimary Care Center Pharmacist s Workforce in Eleven-Year at Ministry of Health in Saudi Arabia
REEARCH ARTICLE OPEN ACCE Journal of Pharmacy Practice and Community edicine., (s):- http://dx.doi.org/./jppcm..s. Primary Care Center Pharmacist s Workforce in Eleven-Year - at inistry of Health in audi
More informationMeasuring Adverse Drug Events on Hospital Medicine Units with the Institute for Healthcare Improvement Trigger Tool: A Chart Review
ORIGINAL RESEARCH Measuring Adverse Drug Events on Hospital Medicine Units with the Institute for Healthcare Improvement Trigger Tool: A Chart Review Iris Lau and Allison Kirkwood ABSTRACT Background:
More informationPharmacy Technicians and Interns: Charting New Territory
Pharmacy Technicians and Interns: Charting New Territory Peter Dippel Pharm.D, BCPS Clinical Pharmacist II Baptist Health Medical Center NLR Objectives Understand what Pharmacist Extenders are and why
More informationThank you for joining us today!
Thank you for joining us today! Please dial 1.800.732.6179 now to connect to the audio for this webinar. To show/hide the control panel click the double arrows. 1 Emergency Room Overcrowding A multi-dimensional
More informationLong-Stay Alternate Level of Care in Ontario Mental Health Beds
Health System Reconfiguration Long-Stay Alternate Level of Care in Ontario Mental Health Beds PREPARED BY: Jerrica Little, BA John P. Hirdes, PhD FCAHS School of Public Health and Health Systems University
More informationQuality health care in intensive
Clinical outcomes after telemedicine intensive care unit implementation* Beth Willmitch, RN, BSN; Susan Golembeski, PhD, RN, CHRC; Sandy S. Kim, MA, MEd; Loren D. Nelson, MD, FACS, FCCM; Louis Gidel, MD,
More information4. Hospital and community pharmacies
4. Hospital and community pharmacies As FIP is the international professional organisation of pharmacists, this paper emphasises the role of the pharmacist in ensuring and increasing patient safety. The
More informationFrom Risk Scores to Impactability Scores:
From Risk Scores to Impactability Scores: Innovations in Care Management Carlos T. Jackson, Ph.D. September 14, 2015 Outline Population Health What is Impactability? Complex Care Management Transitional
More informationThe Cost of Medication Errors in the Emergency Department: Implications for Clinical Pharmacy Practice. Prepared by: Benjamin Bowman
The Cost of Medication Errors in the Emergency Department: Implications for Clinical Pharmacy Practice Prepared by: Benjamin Bowman Table of Contents Executive summary... 3 Introduction...3 Literature
More informationNCLEX PROGRAM REPORTS
for the period of OCT 2014 - MAR 2015 NCLEX-RN REPORTS US48500300 000001 NRN001 04/30/15 TABLE OF CONTENTS Introduction Using and Interpreting the NCLEX Program Reports Glossary Summary Overview NCLEX-RN
More information